PL448280A1 - Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1 - Google Patents

Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1

Info

Publication number
PL448280A1
PL448280A1 PL448280A PL44828024A PL448280A1 PL 448280 A1 PL448280 A1 PL 448280A1 PL 448280 A PL448280 A PL 448280A PL 44828024 A PL44828024 A PL 44828024A PL 448280 A1 PL448280 A1 PL 448280A1
Authority
PL
Poland
Prior art keywords
strains
allergen
bacillus
der
prevention
Prior art date
Application number
PL448280A
Other languages
English (en)
Inventor
Róża Matuszewska
Original Assignee
Biosphertia Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosphertia Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biosphertia Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL448280A priority Critical patent/PL448280A1/pl
Priority to PCT/PL2025/050035 priority patent/WO2025216643A1/en
Publication of PL448280A1 publication Critical patent/PL448280A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/10—Bacillus licheniformis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

W zgłoszeniu ujawniono sposób usuwania alergenu wytwarzanego przez Dermatophagoides pteronissynus z zanieczyszczonej nim powierzchni oraz szczepy oraz zawierające je preparaty nadające się do takiego zastosowania.
PL448280A 2024-04-11 2024-04-11 Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1 PL448280A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL448280A PL448280A1 (pl) 2024-04-11 2024-04-11 Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1
PCT/PL2025/050035 WO2025216643A1 (en) 2024-04-11 2025-04-11 Bacillus spp. strains for use in the prevention or treatment of diseases caused by the der p1 allergen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448280A PL448280A1 (pl) 2024-04-11 2024-04-11 Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1

Publications (1)

Publication Number Publication Date
PL448280A1 true PL448280A1 (pl) 2025-10-13

Family

ID=95783989

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448280A PL448280A1 (pl) 2024-04-11 2024-04-11 Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1

Country Status (2)

Country Link
PL (1) PL448280A1 (pl)
WO (1) WO2025216643A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182184A1 (en) * 1999-07-09 2002-12-05 Pentagonal Holdings, Inc. Composition for the safe removal of indoor allergens
HUE069638T2 (hu) * 2019-01-23 2025-03-28 Heiq Chrisal Nv Szimbiotikus felületkezelõ készítmény
CN116114711B (zh) * 2022-11-04 2023-08-15 武汉悦呼吸科技有限公司 一种室内环境微生物清洁剂及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BERINGS M, JULT A, VERMEULEN H, ET AL.: "Clin Exp Allergy. 2017; 47: 1092–1096", PROBIOTICS-IMPREGNATED BEDDING COVERS FOR HOUSE DUST MITE ALLERGIC RHINITIS: A PILOT RANDOMIZED CLINICAL TRIAL, DOI: https://doi.org/10.1111/cea.12937 *
D. CALZADA, L. MARTÍN‑LÓPEZ, JERÓNIMO CARNÉ: "Scientifc Reports, 2023, 13:10633,", GROWTH, ALLERGEN PROFLE AND MICROBIOME STUDIES IN DERMATOPHAGOIDES PTERONYSSINUS CULTURES, DOI: ttps://doi.org/10.1038/s41598-023-37045-9 *
JAKUBCZYK D., GÓRSKA S.,: "Front. Microbiol. 2021, 12:688137", IMPACT OF PROBIOTIC BACTERIA ON RESPIRATORY ALLERGY DISORDERS., DOI: 10.3389/fmicb.2021.688137 *
JULIE A SWARTZENDRUBER, RYAN W INCROCCI, SAMANTHA A WOLF, ARIEE JUNG, KATHERINE L KNIGHT: "Allergy, 2019, 74(4): 819–821.", BACILLUS SUBTILIS EXOPOLYSACCHARIDE PREVENTS ALLERGIC EOSINOPHILIA, DOI: 10.1111/all.13674 *

Also Published As

Publication number Publication date
WO2025216643A1 (en) 2025-10-16

Similar Documents

Publication Publication Date Title
MX2023009527A (es) Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos.
MX2020007163A (es) Composiciones de acidos/anionicos antimicrobianos y viricidas y usos de estas.
PE20160719A1 (es) Uso de combinaciones que comprenden inductores de defensa de anfitrion y agentes de control biologico para controlar organismos perjudiciales bacterianos en plantas utiles
ATE473630T1 (de) Verfahren zur bekämpfung von pflanzenkrankheitsschäden durch verwendung eines bacillus
WO2022082014A3 (en) Skin targeted immunotolerance
UY36332A (es) Composiciones de bacillus pumilus rt1279 y metodos de uso para benefficiar el crecimiento de las plantas
MX2020013854A (es) Metodo de distribucion micelar.
BRPI0406879A (pt) Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos
AR118509A1 (es) Tratamiento con adsorbente de sílice para eliminar derivados de clorofila de aceites basados en triacilglicerol
MX2024001794A (es) Microorganismos para tratamiento de hidrocarburos o aceite.
ZA202304093B (en) Neuregulin-4 compounds and methods of use
MX2018014621A (es) Composicion biopesticida para uso en la prevencion o para minimizar la enfermedad de la planta.
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
AR046448A1 (es) Un metodo para tratar una tela no tejida para mejorar la repelencia al alcohol de la tela no tejida, la tela no tejida tratada con dicho metodo y un producto para el control de las infecciones que contiene dicha tela
MX2025006782A (es) Degradadores de la cinasa 4 asociada al receptor de interleucina-1 (irak4) y usos de los mismos
MX2021006072A (es) Robots de pequeña escala para la erradicación de biopelículas.
PL448280A1 (pl) Szczepy Bacillus sp. do stosowania w zapobieganiu lub leczeniu chorób wywołanych przez alergen Der p1
NO20050839L (no) Kontorprodukter inneholdende antimikrobielle midler
ATE378309T1 (de) Verfahren zur reinigung und herstellung von fluorkohlenwasserstoffen
CL2022000779A1 (es) Composiciones y métodos para la estimulación ovárica controlada (divisional de la solicitud no. 202100928)
WO2022011271A3 (en) Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
EP4234022A3 (en) Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject
ECSP24009774A (es) Uso fungicida
BR112022003639A8 (pt) Agente bioestimulante para tratamento de plantas e/ou de sementes de plantas
WO2025024305A3 (en) Irak4 degraders and uses thereof